MustGrow Biologics Corp.
MGROF
$0.37
$0.00-0.16%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 621.40K | 573.00K | 2.06M | 2.64M | 84.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 621.40K | 573.00K | 2.06M | 2.64M | 84.90K |
| Cost of Revenue | 660.00K | 506.00K | 1.76M | 2.31M | 111.60K |
| Gross Profit | -38.60K | 66.90K | 301.60K | 321.10K | -26.70K |
| SG&A Expenses | 811.70K | 1.60M | 863.30K | 1.10M | 560.90K |
| Depreciation & Amortization | 9.60K | 9.70K | 9.60K | 7.50K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.56M | 2.23M | 2.69M | 3.51M | 851.70K |
| Operating Income | -943.00K | -1.65M | -630.10K | -872.60K | -766.80K |
| Income Before Tax | -1.51M | -1.76M | -787.00K | -1.14M | -866.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.51M | -1.76M | -787.00K | -1.14M | -866.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.51M | -1.76M | -787.00K | -1.14M | -866.60K |
| EBIT | -943.00K | -1.65M | -630.10K | -872.60K | -766.80K |
| EBITDA | -936.10K | -1.65M | -623.20K | -865.90K | -- |
| EPS Basic | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 58.90M | 54.71M | 52.13M | 54.68M | 51.64M |
| Average Diluted Shares Outstanding | 58.90M | 54.71M | 52.13M | 54.68M | 51.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |